BDSX
Biodesix IncCompany with tickers: BDSX
CIK
1439725
CUSIP
09075X207
Shares Outstanding
10,355,809
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $17,958,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $27,094,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Research & Development | $2,870,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Operating Income | $-9,136,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Net Income | $-11,101,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $-1.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $-1.52 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |